<?xml version="1.0" encoding="UTF-8"?>
<p id="p0050">Convalescent plasma has also been used in the setting of influenza, which is relevant to its application against coronavirus. Data on the use of convalescent plasma in the treatment of influenza dates back the 1918 H1N1 pandemic. A meta-analysis of several related studies published between 1918 and 1925 revealed decreased case-fatality rate in the treated group vs the nontreated controls (16% vs. 37%, respectively) [
 <xref rid="bb0090" ref-type="bibr">18</xref>]; there was also a difference in case-fatality rate noted in patients who received convalescent plasma early compared to those who were transfused later in their disease course (19% vs 59%, respectively). None of the included studies were blinded or randomized and most contained heterogeneous and sometimes archaic treatment methods.
</p>
